ChemoCentryx (CCXI) Tops Q3 EPS by 13c
Tweet
Share
E-mail
Get Alerts CCXI Hot Sheet
Join SI Premium – FREE
ChemoCentryx (NASDAQ: CCXI) reported Q3 EPS of ($0.32), $0.13 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $17.7 million versus the consensus estimate of $13.48 million.
For earnings history and earnings-related data on ChemoCentryx (CCXI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Accuray (ARAY) Tops Q4 EPS by 1c
- John B. Sanfilippo & Son (JBSS) Misses Q4 EPS by 59c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
